International Patent: TARGETED THERAPY OF CANCER BY PHARMACOLOGICAL ACTIVATION OF MTOR

GENEVA, July 1 -- HEINRICH-HEINE-UNIVERSITÄT DÜSSELDORF filed a patent application (EP2025/086821) for “TARGETED THERAPY OF CANCER BY PHARMACOLOGICAL ACTIVATION OF MTOR”. With publication no. WO/2026/125700, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/365

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....